ARROWHEAD PHARMACEUTICALS, INC. - Common Stock (ARWR)

CUSIP: 04280A100

Q3 2025 13F Holders as of 30 Sep 2025

Type / Class
Equity / Common Stock
Shares outstanding
135,488,140
Total 13F shares
110,897,224
Share change
+5,233,340
Total reported value
$3,823,917,269
Put/Call ratio
27%
Price per share
$34.49
Number of holders
300
Value change
+$261,693,126
Number of buys
164
Number of sells
121

Quarterly Holders Quick Answers

What is CUSIP 04280A100?
CUSIP 04280A100 identifies ARWR - ARROWHEAD PHARMACEUTICALS, INC. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of ARROWHEAD PHARMACEUTICALS, INC. - Common Stock (ARWR) as of Q3 2025

As of 30 Sep 2025, ARROWHEAD PHARMACEUTICALS, INC. - Common Stock (ARWR) was held by 300 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 110,897,224 shares. The largest 10 holders included BlackRock, Inc., VANGUARD GROUP INC, Avoro Capital Advisors LLC, STATE STREET CORP, FMR LLC, Slate Path Capital LP, GEODE CAPITAL MANAGEMENT, LLC, Siren, L.L.C., Driehaus Capital Management LLC, and ARROWSTREET CAPITAL, LIMITED PARTNERSHIP. This page lists 300 institutional shareholders reporting positions in this security for the Q3 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.